Nabriva Therapeutics is a biotechnology company focused on developing antibiotics for the treatment of patients with infections caused by resistant pathogens.

NAMSA is a Medical Research Organization accelerating product development through integrated laboratory, clinical and consulting services.

NanoCell Therapeutics, Inc. is a company developing a new biological entity-based targeted gene therapy platform.

NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses.

NAF is a membership supported nonprofit organization established in 1957 to help persons with Ataxia and their families.

The National Blood Clot Alliance focuses on building awareness and building community among people who are affected by blood clots.

The National CMV Foundation is a non-profit organization dedicated to eliminating childhood death & disability due to congenital cytomegalovirus.

Navigate is a management consulting firm that helps clients solve their business problems.

Ashfield Excellence Academy provides training, skill assessments, and processes consultancy for the pharmaceutical and healthcare industries.

NB2 Corp. develops intellectual property for licensing.

NEPEC is a nonprofit corporation of five private accredited colleges and universities located in Lackawanna and Luzerne counties, northeast Pennsylvania.

NephCure Kidney International’s mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome.

NeuBase Therapeutics addresses genetic diseases caused by mutant proteins with a single, cohesive approach.

NeuEsse is a life sciences startup developing a human skin substitute.

NeuExcell is a privately held early-stage gene technology company focused to improve the lives of patients suffering from neuro-degenerative diseases.

Neuralert is a spin-out from the University of Pennsylvania. It's invention addresses the problem of late or undetected stroke in hospitalized patients.

Neuraptive is creating innovative novel therapies for nerve repairs to improve clinical outcomes for patients and surgeons who care for them.

Neuro-Innovators is a clinical-stage drug company focused on engineering drugs to accelerate brain neuroplasticity for patients with brain injuries. 

Neurokappa Therapeutics is a start-up biopharmaceutical company focused on the development of Salvinorin A for the prevention/treatment of cerebral vasospasm.

Neuronetics is designing and developing products that improve the quality of life for people suffering from neurohealth conditions.

New Zealand Trade and Enterprise is New Zealand's economic development and trade promotion agency.

Newfront is an insurance brokerage that leverages technology to vastly simplify the buying process for clients and the selling process for brokers.

Newmark Group is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle.

NexEos Bio is a medical diagnostics and therapeutics company dedicated to improving the detection, diagnosis & treatment of patients living with chronic disease

Nexstone Innovation is a biopharma drug development company established by former partners and senior executives from NeXeption.

NGT BioPharma Consultants offers strategic and operational consultancy to expedite the development of small molecule and biologic drug candidates.

NMS Labs is a bioanalytical toxicology laboratory recognized as a leader in esoteric clinical and forensic services.

NORD is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them.

Northampton Community College is committed to quality, affordable higher education.

NovaPharm is a late stage drug development company focused on new treatments for Complex Regional Pain Syndrome.

Novartis is reimagining medicine to improve and extend people’s lives.

Noveome Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation biologic therapeutics.

Novocure is a global oncology company working to extend survival in aggressive forms of cancer through the development of Tumor Treating Fields.

NRx Pharmaceuticals draws upon decades of collective experience applying innovative science to improved health to patients.

Nucleus Network is the only Phase 1 clinical research organization in the world to have Phase 1 facilities located in Australia and the USA.

Nuritas targets, predicts and unlocks novel bioactive peptides from food sources. These deliver highly specific, efficient and life-changing health solutions.